Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery
- PMID: 26409728
- PMCID: PMC4658259
- DOI: 10.1016/j.ophtha.2015.08.024
Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery
Abstract
Purpose: To study the relationship of chemoprophylaxis and other factors with the occurrence of acute, clinical, postoperative macular edema.
Design: Retrospective cohort study. The drug regimens consisted of postoperative topical prednisolone acetate (PA) alone or with a nonsteroidal anti-inflammatory drug (NSAID) or intraoperative subconjunctival injection of 2 mg triamcinolone acetonide (TA) alone.
Participants: Patients undergoing phacoemulsification at Kaiser Permanente, Diablo Service Area, Northern California, from 2007 through 2013.
Methods: We identified incident macular edema diagnoses that had been recorded 5 to 120 days after phacoemulsification with visual acuity 20/40 or worse and evidence of macular thickening by optical coherence tomography. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained from logistic regression analysis, conditioned on the surgeon and adjusted for year, patient age and race, diabetic retinopathy status, other ocular comorbidities, systemic comorbidities, and posterior capsular rupture status.
Main outcome measures: Incident rates of acute, clinical, postoperative macular edema.
Results: We confirmed 118 cases among 16 070 cataract surgeries (incidence, 0.73%). Compared with PA alone, the OR for the relationship of macular edema with PA+NSAID was 0.45 (95% CI, 0.21-0.95) and that for TA injection was 1.21 (95% CI, 0.48-3.06). The frequency of intraocular pressure spikes of 30 mmHg or more between postoperative days 16 and 45 was 0.6% in the topical PA group, 0.3% in the topical PA+NSAID group (P = 0.13), and 0.8% for the TA group (P = 0.52). Black race was associated with a risk of macular edema (OR, 2.86; 95% CI, 1.41-5.79).
Conclusions: Adding a prophylactic NSAID to PA treatment was associated with a reduced risk of macular edema with visual acuity of 20/40 or worse. The risk and safety of TA injection were similar to those of PA alone. Further research is needed on the prognostic significance of postoperative macular edema, the role of prophylaxis, the risk among black people, and the effectiveness of depot medications.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Re: Shorstein et al.: Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgery (Ophthalmology 2015;122:2450-6).Ophthalmology. 2016 Sep;123(9):e54-5. doi: 10.1016/j.ophtha.2016.01.059. Ophthalmology. 2016. PMID: 27549890 No abstract available.
-
Reply.Ophthalmology. 2016 Sep;123(9):e55. doi: 10.1016/j.ophtha.2016.02.024. Ophthalmology. 2016. PMID: 27549892 No abstract available.
References
-
- Centers for Disease Control. U.S. Outpatient Surgeries on the Rise. [Accessed April 22, 2014]; http://www.cdc.gov/media/pressrel/2009/r090128.htm.
-
- Greenberg PB, Tseng VL, Wu WC, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology. 2011;118(3):507–514. - PubMed
-
- Shelsta HN, Jampol LM. Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina. 2011;31(1):4–12. - PubMed
-
- Hunter AA, Modjtahedi SP, Long K, et al. Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema. J Cataract Refract Surg. 2014;40(4):626–631. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
